Adverse Effect in Patients with Psoriasis Treated with Interleukin 17A Inhibitor- Secukinumab
DOI: https://doi.org/10.2478/sjecr-2022-0013 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Language: English
Submitted on: Aug 24, 2021
Accepted on: Mar 26, 2022
Published on: May 27, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2022 Ardea Milidrag, Medo Gutić, Ivana Rodić, Ana Pjevač, Tatjana Mladenović, Vesna Miličić, Ana Ravić-Nikolić, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.